Reply: Hypertension in developing countries

The Lancet

Volumn 380, Issue 9852, 2012, Pages 1471-1472

  Koopman, J J E ^a   Van Bodegom, D ^a,b   Beenakker, K G M ^a   Jukema, J W ^a   Westendorp, R G J ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Leyden Academy on Vitality and Ageing   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DISEASE; DEVELOPING COUNTRY; ELECTROCARDIOGRAPHY; GHANA; HUMAN; HYPERTENSION; LETTER; LIFESTYLE MODIFICATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; URBAN AREA; NOTE;

DEVELOPING COUNTRIES; HUMANS; HYPERTENSION;

EID: 84867765482     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61841-8     Document Type: Letter

References (5)

1. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet 2012; 380: 611-19.
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-53.
3. Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa: the Interheart Africa Study. Circulation 2005; 112: 3554-61.
4. Koopman JJE, Van Bodegom D, Jukema JW, Westendorp RGJ. Risk of cardiovascular disease in a traditional African population with a high infectious load: a population-based study. PLoS One 2012; 7: e46855.
5. Yusuf S, Hawken S, Ounpuu S, et al. effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2004; 364: 937-52.